Company intelligence / Profile preview
Biotie Therapies
Turku, Western FI, Finlandbiotie.com ↗
- Ownership
- Private
- Employees
- ~38
- Development stage
- Other
01
Overview
Biotie's most advanced product was Selincro® for alcohol dependence—approved and marketed in Europe by Lundbeck. Tozadenant reached Phase 3 trials for Parkinson’s disease as an adjunct to levodopa. SYN120 completed early clinical studies targeting cognitive/psychotic symptoms. BTT1023 was a Phase 2 mAb program for primary sclerosing cholangitis with orphan drug designation. The company had additional preclinical assets but focused on CNS and liver indications at the time of its acquisition by Acorda Therapeutics in January 2016
- Therapeutic areas
- PulmonologyPsychiatryGastroenterologyNeurology
- Modalities
- Small moleculesmonoclonal antibodies (mAbs)biologics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
H.Lundbeck A/S(Selincro commercialization)UCBRoche(legacy asset licenses via Synosia deal)Seikagaku(VAP‑1 antibody rights Asia-Pacific)
Beyond the preview
Go deeper on Biotie Therapies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biotie Therapies.